Tag: generalized myasthenia gravis

Alexion waits for FDA’s OK for generalized myasthenia gravis drug
March 8, 2017 Off

Alexion waits for FDA’s OK for generalized myasthenia gravis drug

By Dino Mustafić

U.S. Food and Drug Administration(FDA) has accepted for review the Alexion Pharmaceuticals’s supplemental Biologics License Application (sBLA) to extend the indication for Soliris (eculizumab) as a potential treatment for patients with refractory generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive.